These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Therapeutic monoclonal antibodies: trends in development and approval in the US. Reichert JM Curr Opin Mol Ther; 2002 Apr; 4(2):110-8. PubMed ID: 12044031 [TBL] [Abstract][Full Text] [Related]
3. Development and production of commercial therapeutic monoclonal antibodies in Mammalian cell expression systems: an overview of the current upstream technologies. Chartrain M; Chu L Curr Pharm Biotechnol; 2008 Dec; 9(6):447-67. PubMed ID: 19075685 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody successes in the clinic. Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394 [TBL] [Abstract][Full Text] [Related]
10. mAbs: a business perspective. Scolnik PA MAbs; 2009; 1(2):179-84. PubMed ID: 20061824 [TBL] [Abstract][Full Text] [Related]
11. Development trends for human monoclonal antibody therapeutics. Nelson AL; Dhimolea E; Reichert JM Nat Rev Drug Discov; 2010 Oct; 9(10):767-74. PubMed ID: 20811384 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development. Yan L; Beckman RA Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569 [TBL] [Abstract][Full Text] [Related]
13. Metrics for antibody therapeutics development. Reichert JM MAbs; 2010; 2(6):695-700. PubMed ID: 20930555 [TBL] [Abstract][Full Text] [Related]
14. Current and experimental antibody-based therapeutics: insights, breakthroughs, setbacks and future directions. Murad JP; Lin OA; Espinosa EV; Khasawneh FT Curr Mol Med; 2013 Jan; 13(1):165-78. PubMed ID: 22834842 [TBL] [Abstract][Full Text] [Related]
15. Human monoclonal antibodies from transgenic mice. Lonberg N Handb Exp Pharmacol; 2008; 181(181):69-97. PubMed ID: 18071942 [TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical R&D performance by firm size: approval success rates and economic returns. DiMasi JA Am J Ther; 2014; 21(1):26-34. PubMed ID: 23344103 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to watch in 2019. Kaplon H; Reichert JM MAbs; 2019; 11(2):219-238. PubMed ID: 30516432 [TBL] [Abstract][Full Text] [Related]
19. The growth and potential of human antiviral monoclonal antibody therapeutics. Marasco WA; Sui J Nat Biotechnol; 2007 Dec; 25(12):1421-34. PubMed ID: 18066039 [TBL] [Abstract][Full Text] [Related]
20. An Introduction to "Recent Trends in the Biotechnology Industry: Development and Manufacturing of Recombinant Antibodies and Proteins". Pohlscheidt M; Kiss R; Gottschalk U Adv Biochem Eng Biotechnol; 2018; 165():1-8. PubMed ID: 29748871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]